More News

13 Dec 2017 Evotec Enters into Research Collaboration with CRTD to Discover Novel Therapies for Retinal Diseases
12 Dec 2017 Vertex and CRISPR Therapeutics to Co-Develop and Co-Commercialize CTX001 as CRISPR/Cas9 Gene Edited Treatment for Sickle Cell Disease and ß-Thalassemia
12 Dec 2017 Repros Therapeutics Inc.® Announces Acquisition by Allergan plc
11 Dec 2017 Ionis Pharmaceuticals Licenses IONIS-HTT Rx to Partner Following Successful Phase 1/2a Study in Patients with Huntington's Disease
11 Dec 2017 Medigene collaborates with RXi Pharmaceuticals to further sharpen its therapeutic T cells
08 Dec 2017 Gilead Sciences and Kite to Acquire Cell Design Labs
07 Dec 2017 Aerogen Pharma and Lyomark Pharma Partner to Develop Inhaled Surfactant, Begin a Phase 2 Clinical Trial
07 Dec 2017 bluebird bio and TC BioPharm Announce Strategic Collaboration to Research and Develop Gamma Delta CAR T Cell Product Candidates for Cancer Immunotherapy
07 Dec 2017 Alexion and Halozyme Enter License Agreement for ENHANZE Technology
07 Dec 2017 XOMA Announces Exclusive License Agreement for XOMA 358 with Rezolute, Inc.
07 Dec 2017 Carmot Enters a Multi-Year Drug Discovery Collaboration With Amgen
07 Dec 2017 BioInvent and Transgene collaborate on next generation oncolytic viruses encoding an anti-CTLA-4 antibody to treat solid tumors
06 Dec 2017 Ayala Pharmaceuticals, Founded by Israel Biotech Fund, aMoon and Harel Insurance, Enters Exclusive Worldwide License Agreement with Bristol-Myers Squibb (BMS) to Develop Cancer Treatments
06 Dec 2017 TetraGenetics and ModiQuest Collaborating for the Discovery of Therapeutic Antibodies Against KCa3.1
06 Dec 2017 Juno Therapeutics Signs Licensing Agreements with Lilly, OncoTracker, and Fred Hutchinson Cancer Research Center to Advance Its BCMA-Directed Engineered T Cell Program in Multiple Myeloma with Gamma Secretase Inhibition
06 Dec 2017 Obsidian Therapeutics Announces $49.5 Million Series A Financing to Develop Controllable Cell and Gene Therapy Products
05 Dec 2017 CSL and Vitaeris Announce Strategic Partnership with Option to Acquire
05 Dec 2017 Led by OrbiMed Israel and Peter Thiel, ChemomAb Raises $10 Million in Series B Funding
04 Dec 2017 Mustang Bio Announces License Agreement with Harvard University, and Research Collaboration with Beth Israel Deaconess Medical Center, to Develop CRISPR/Cas9-Enhanced CAR T Therapies
04 Dec 2017 Takeda announces research collaboration in ALS with Montreal Neurological Institute
04 Dec 2017 FDA Approves Amgen's Repatha® (evolocumab) To Prevent Heart Attack And Stroke
01 Dec 2017 Astellas Acquires Mitobridge Under Existing Collaboration
30 Nov 2017 MorphoSys Signs Regional License Agreement for Antibody MOR202 with I-Mab
29 Nov 2017 Regeneron and Decibel Therapeutics Announce Strategic Collaboration to Discover and Develop Therapeutics for Hearing Loss and Tinnitus
29 Nov 2017 Melinta Therapeutics Enters Into Agreement to Acquire Infectious Disease Business from The Medicines Company

La Merie Biologics

FREE Weekly News Bulletin

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing